Navigare Ventures

About Navigare Ventures

Navigare Ventures AB is the science-driven venture investment arm of the Wallenberg ecosystem, founded in 2021 and headquartered in Stockholm at Arsenalsgatan 8C. The firm is a wholly-owned subsidiary of Wallenberg Investments AB, the asset management entity that oversees the private holdings of the Wallenberg Foundations including the Knut and Alice Wallenberg Foundation and its sister foundations. This places Navigare Ventures inside one of Europe's most established industrial-philanthropic networks, alongside Investor AB, FAM AB and the broader Wallenberg foundation system that has supported Swedish basic research since 1917. Navigare Ventures operates as an evergreen vehicle backed by a single institutional sponsor rather than a traditional closed-end fund, with no externally raised limited partner capital and no publicly disclosed assets-under-management figure. As of 2024 the firm operates with a team of approximately 15 people including seven partners.

Investment thesis

Navigare Ventures is an early-stage science investor backing Seed and Series A rounds with capacity to follow on into later stages for companies translating deep research into commercial products. The thematic remit is narrow and deliberately scientific, covering advanced computing and quantum technologies, synthetic biology and bio-innovation, advanced materials and nanotechnology, and data-driven life sciences. Geography is centred on Sweden and the broader Nordic university ecosystem including Karolinska, KTH, Chalmers, Uppsala and Linköping, although the firm has done deals with international co-investors. Ticket sizes are not publicly disclosed, with observable cheque sizes ranging from approximately USD 5 million to USD 20 million per round. Because Navigare Ventures has a single limited partner in Wallenberg Investments AB, the firm has no external fundraising obligations and is positioned as a patient capital partner emphasising decade-plus holding periods. Value creation is delivered through capital, scientific networks via the Wallenberg foundations, and industrial networks via the broader Wallenberg portfolio.

Recent activity

Recent portfolio additions disclosed by Navigare Ventures include SweGaN in semiconductors (2024), Interspectral in additive-manufacturing software (2024), Profundus in medical imaging (2024), Intuicell in neuro-inspired AI (2023), AlixLabs in semiconductor equipment (2023), EnginZyme in biomanufacturing (2022), Rarity Bioscience in diagnostics (2022) and Pixelgen Technologies in biotech tools (2022). Earlier holdings include Elypta in cancer diagnostics, Arevo in agritech and ScandiBio in therapeutics. The firm publicly discloses no exits to date, consistent with its 2021 launch date and deep-tech and life-sciences thesis. Detailed buyer names and multiple data available on Pro at €49/month.